NCT04650620View on ClinicalTrials.gov

Study to Evaluate the Performance and Safety of the Medical Device Plenhyage®

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

April 2, 2021

Study Completion Date

April 2, 2021

Conditions
Wrinkle
Interventions
DEVICE

Plenhyage® thin

0.75%

DEVICE

Plenhyage® medium

2%

DEVICE

Plenhyage® strong

2.5%

Trial Locations (1)

300425

SCM Dr. Rosu, Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

I.R.A. Istituto Ricerche Applicate S.p.A.

NETWORK

NCT04650620 - Study to Evaluate the Performance and Safety of the Medical Device Plenhyage® | Biotech Hunter | Biotech Hunter